Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in Kayseri, Turkey.


Journal

Primary care diabetes
ISSN: 1878-0210
Titre abrégé: Prim Care Diabetes
Pays: England
ID NLM: 101463825

Informations de publication

Date de publication:
10 2020
Historique:
received: 08 11 2019
revised: 08 01 2020
accepted: 14 01 2020
pubmed: 8 2 2020
medline: 18 8 2021
entrez: 8 2 2020
Statut: ppublish

Résumé

Diabetes is a major health problem worldwide, as its prevalence is increasing dramatically. Lifestyle modification can delay or prevent the onset of type 2 diabetes. Therefore, screening for prediabetes and type 2 diabetes risk through an assessment of risk factors is important. The objective of the study was to investigate the risk for type 2 diabetes using the Finnish Diabetes Risk Score (FINDRISC) in Kayseri. In total, 1500 adults aged 18 years or older were interviewed using the FINDRISC as Diabetes Risk Questionnaire and fasting serum glucose levels. The findings of FINDRISC were grouped according to gender and a score of 15 and above was accepted as a high risk in terms of Type 2 diabetes. 13.5% of the participants were in the high- risk group. There was a statistically significant relationship between total FINDRISC score and gender (p < 0.001). While 15.2% of the women were in the high -risk group, 12.4% of the men were in the high- risk group. The percentage of women in the low-risk group (35.9%) is less than the men with low- risk of diabetes (38.5%). As the BMI increased, the individuals were found to have a high risk evaluated with the use of FINDRISC. 14.3% of women with waist circumference >88 and 6.7% of men with waist circumference >102 were in the high- risk group. (p < 0.001) CONCLUSIONS: Risk of diabetes was found to be higher with the FINDRISC score as the BMI and waist circumference increased. FINDRISC can be used in the primary care for this purpose; fast and easy to be applied.

Identifiants

pubmed: 32029385
pii: S1751-9918(19)30514-5
doi: 10.1016/j.pcd.2020.01.002
pii:
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

488-493

Informations de copyright

Copyright © 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Auteurs

A Timucin Atayoglu (AT)

Department of Family Medicine, Medical Faculty, International Medipol University, Istanbul, Turkey. Electronic address: atimucinatayoglu@gmail.com.

Neriman Inanc (N)

Department of Nutrition and Dietetics, Faculty of Health Sciences, Naci Yazgan University, Kayseri, Turkey. Electronic address: nerimaninanc@gmail.com.

Eda Başmisirli (E)

Department of Nutrition and Dietetics, Faculty of Health Sciences, Naci Yazgan University, Kayseri, Turkey. Electronic address: edadmrcgl@gmail.com.

Aslı Gizem Çapar (AG)

Department of Nutrition and Dietetics, Faculty of Health Sciences, Naci Yazgan University, Kayseri, Turkey. Electronic address: gizem_pekmezci@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH